fda decision tirzepatide approval for Zepbound: FSU researcher available for context on newly approved weight loss treatment FDA approval for Zepbound (tirzepatide)

A second Phase I study in adults with diabetic kidney disease reported a D+Q dependent clearance of senescent adipose and skin cells and reduced SASP within 11 days of treatment (106)

One of our primary outcomes was hospitalization for worsening of heart failure

If you have underlying sleep issues, evening injections don't worsen them

The tech didnt work

How B12 Supports Weight Loss Efforts In addition to boosting energy levels, B12 injections can support overall weight loss efforts by improving mood and reducing feelings of fatigue

While aiming for optimal glycemic targets, it is essential to balance the benefits of tight glucose control against the risks of hypoglycemia, especially in individuals with long-standing diabetes or comorbidities